{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:16:59Z","timestamp":1768288619673,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,3]]},"DOI":"10.7759\/cureus.48222","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T16:07:42Z","timestamp":1699027662000},"source":"Crossref","is-referenced-by-count":2,"title":["Refractory Status Epilepticus Associated With a Pathogenic Variant in TNFRSF13B"],"prefix":"10.7759","author":[{"given":"Jennifer H","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Scanlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonhee","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie N","family":"LaBuzetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasie","family":"Dunn-Pirio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14022","article-title":"New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives","volume":"59","author":"Gaspard N","year":"2018","unstructured":"Gaspard N, Hirsch LJ, Sculier C, et al.. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives. Epilepsia. 2018, 59:745-52. 10.1111\/epi.14022","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert DJ","year":"2016","unstructured":"Bogaert DJ, Dullaers M, Lambrecht BN, Vermaelen KY, De Baere E, Haerynck F. Genes associated with common variable immunodeficiency: one diagnosis to rule them all?. J Med Genet. 2016, 53:575-90. 10.1136\/jmedgenet-2015-103690","journal-title":"J Med Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.11.039","article-title":"Structural noninfectious manifestations of the central nervous system in common variable immunodeficiency disorders","volume":"8","author":"van de Ven A","year":"2020","unstructured":"van de Ven A, Mader I, Wolff D, et al.. Structural noninfectious manifestations of the central nervous system in common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2020, 8:1047-1062.e6. 10.1016\/j.jaip.2019.11.039","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3283141200","article-title":"Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency","volume":"8","author":"Lee JJ","year":"2008","unstructured":"Lee JJ, Ozcan E, Rauter I, Geha RS. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol. 2008, 8:520-6. 10.1097\/ACI.0b013e3283141200","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang L","year":"2007","unstructured":"Zhang L, Radigan L, Salzer U, et al.. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol. 2007, 120:1178-85. 10.1016\/j.jaci.2007.10.001","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.06.004","article-title":"TACI deficiency - a complex system out of balance","volume":"71","author":"Salzer U","year":"2021","unstructured":"Salzer U, Grimbacher B. TACI deficiency - a complex system out of balance. Curr Opin Immunol. 2021, 71:81-8. 10.1016\/j.coi.2021.06.004","journal-title":"Curr Opin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.06.012","article-title":"Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation","volume":"120","author":"Castigli E","year":"2007","unstructured":"Castigli E, Wilson SA, Elkhal A, Ozcan E, Garibyan L, Geha RS. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. J Allergy Clin Immunol. 2007, 120:885-91. 10.1016\/j.jaci.2007.06.012","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1914","article-title":"The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88","volume":"11","author":"He B","year":"2010","unstructured":"He B, Santamaria R, Xu W, et al.. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol. 2010, 11:836-45. 10.1038\/ni.1914","journal-title":"Nat Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7531","article-title":"TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells","volume":"178","author":"Treml LS","year":"2007","unstructured":"Treml LS, Carlesso G, Hoek KL, et al.. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol. 2007, 178:7531-9. 10.4049\/jimmunol.178.12.7531","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203468","article-title":"Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice","volume":"192","author":"Uslu K","year":"2014","unstructured":"Uslu K, Coleman AS, Allman WR, Katsenelson N, Bram RJ, Alugupalli KR, Akkoyunlu M. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice. J Immunol. 2014, 192:3582-95. 10.4049\/jimmunol.1203468","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69854","article-title":"CVID-associated TACI mutations affect autoreactive B cell selection and activation","volume":"123","author":"Romberg N","year":"2013","unstructured":"Romberg N, Chamberlain N, Saadoun D, et al.. CVID-associated TACI mutations affect autoreactive B cell selection and activation. J Clin Invest. 2013, 123:4283-93. 10.1172\/JCI69854","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes","volume":"113","author":"Salzer U","year":"2009","unstructured":"Salzer U, Bacchelli C, Buckridge S, et al.. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 2009, 113:1967-76. 10.1182\/blood-2008-02-141937","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/039463201202500210","article-title":"The impact of TACI mutations: from hypogammaglobulinemia in infancy to autoimmunity in adulthood","volume":"25","author":"Barroeta Seijas AB","year":"2012","unstructured":"Barroeta Seijas AB, Graziani S, Cancrini C, et al.. The impact of TACI mutations: from hypogammaglobulinemia in infancy to autoimmunity in adulthood. Int J Immunopathol Pharmacol. 2012, 25:407-14. 10.1177\/039463201202500210","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8390356","article-title":"Clinical associations of biallelic and monoallelic TNFRSF13B variants in Italian primary antibody deficiency syndromes","volume":"2016","author":"Pulvirenti F","year":"2016","unstructured":"Pulvirenti F, Zuntini R, Milito C, et al.. Clinical associations of biallelic and monoallelic TNFRSF13B variants in Italian primary antibody deficiency syndromes. J Immunol Res. 2016, 2016:8390356. 10.1155\/2016\/8390356","journal-title":"J Immunol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.07.342","article-title":"Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations","volume":"73","author":"Freiberger T","year":"2012","unstructured":"Freiberger T, Rav\u010dukov\u00e1 B, Grodeck\u00e1 L, et al.. Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations. Hum Immunol. 2012, 73:1147-54. 10.1016\/j.humimm.2012.07.342","journal-title":"Hum Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9793-x","article-title":"Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)","volume":"33","author":"Koopmans W","year":"2013","unstructured":"Koopmans W, Woon ST, Brooks AE, Dunbar PR, Browett P, Ameratunga R. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI). J Clin Immunol. 2013, 33:68-73. 10.1007\/s10875-012-9793-x","journal-title":"J Clin Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.10.029","article-title":"TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes","volume":"131","author":"Martinez-Gallo M","year":"2013","unstructured":"Martinez-Gallo M, Radigan L, Almej\u00fan MB, Mart\u00ednez-Pomar N, Matamoros N, Cunningham-Rundles C. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. J Allergy Clin Immunol. 2013, 131:468-76. 10.1016\/j.jaci.2012.10.029","journal-title":"J Allergy Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-213025","article-title":"Role of TNFRSF13B variants in patients with common variable immunodeficiency","volume":"114","author":"Mart\u00ednez-Pomar N","year":"2009","unstructured":"Mart\u00ednez-Pomar N, Detkov\u00e1 D, Arostegui JI, et al.. Role of TNFRSF13B variants in patients with common variable immunodeficiency. Blood. 2009, 114:2846-8. 10.1182\/blood-2009-05-213025","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer U","year":"2005","unstructured":"Salzer U, Chapel HM, Webster AD, et al.. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005, 37:820-8. 10.1038\/ng1600","journal-title":"Nat Genet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0336-8","article-title":"Neurologic complications of common variable immunodeficiency","volume":"36","author":"Nguyen JT","year":"2016","unstructured":"Nguyen JT, Green A, Wilson MR, DeRisi JL, Gundling K. Neurologic complications of common variable immunodeficiency. J Clin Immunol. 2016, 36:793-800. 10.1007\/s10875-016-0336-8","journal-title":"J Clin Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000449","article-title":"Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis","volume":"30","author":"Spatola M","year":"2017","unstructured":"Spatola M, Dalmau J. Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Curr Opin Neurol. 2017, 30:345-53. 10.1097\/WCO.0000000000000449","journal-title":"Curr Opin Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/186168-refractory-status-epilepticus-associated-with-a-pathogenic-variant-in-tnfrsf13b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:53Z","timestamp":1707509393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/186168-refractory-status-epilepticus-associated-with-a-pathogenic-variant-in-tnfrsf13b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.48222","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,3]]}}}